Detalhe da pesquisa
1.
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.
PLoS Med
; 18(7): e1003656, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34228725
2.
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level.
EBioMedicine
; 90: 104545, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37002990
3.
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia.
Nat Microbiol
; 7(6): 896-908, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35637329
4.
Modular Lentiviral Vectors for Highly Efficient Transgene Expression in Resting Immune Cells.
Viruses
; 13(6)2021 06 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34207354
5.
Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection.
Cell Rep Med
; 2(4): 100228, 2021 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33748788